Drug Profile
Research programme: needle-free injectables - Glide
Alternative Names: Exenatide SDI®; Glide teriparatide; Teriparatide SDI®Latest Information Update: 24 Aug 2023
Price :
$50
*
At a glance
- Originator Glide Technologies
- Class Antihyperglycaemics; Osteoporosis therapies; Peptide hormones
- Mechanism of Action Glucagon-like peptide 1 stimulants; Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Osteoporosis; Type 2 diabetes mellitus
Most Recent Events
- 24 Aug 2023 Discontinued - Preclinical for Osteoporosis in United Kingdom (SC)
- 24 Aug 2023 Discontinued - Preclinical for Type 2 diabetes mellitus in United Kingdom (Parenteral)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Type-2-diabetes-mellitus in United Kingdom (Parenteral, Injection)